48 results on '"Kunitoh, Hideo"'
Search Results
2. One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis)
3. MO1-4 One-year incidence of venous thromboembolism in lung cancer patients in the Cancer-VTE Registry
4. Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC—Real-World Data in the Era of Molecularly Targeted Agents and Immunotherapy
5. One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry
6. A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707)
7. Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503
8. Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women
9. A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer
10. A phase II study of low-dose erlotinib in frail patients with EGFR-mutant non-small cell lung cancer: TORG1425
11. P1.05-051 Safety and Compliance Data of the Phase III Study of Adjuvant Chemotherapy in Completely Resected P-Stage I Non-Small Cell Lung Cancer: JCOG0707
12. P1.05-063 Multicenter Observational Study of Patients with Resected Early-Staged NSCLC, Who Were Excluded from an Adjuvant Chemotherapy Trial
13. OA10.02 Association of Variations in HLA-Class II and Other Loci with Susceptibility to EGFR-Mutated Lung Adenocarcinoma
14. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
15. A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911
16. Cytotoxic chemotherapy may overcome the development of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) therapy
17. Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer
18. Phase I Study of Concurrent High-Dose Three-Dimensional Conformal Radiotherapy With Chemotherapy Using Cisplatin and Vinorelbine for Unresectable Stage III Non-Small-Cell Lung Cancer
19. Genetic variations of orosomucoid genes associated with serum alpha‐1‐acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer
20. Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 Genes to the Risk for Lung Squamous Cell Carcinoma
21. Genome-Wide Association Study on Overall Survival of Advanced Non-small Cell Lung Cancer Patients Treated with Carboplatin and Paclitaxel
22. A Phase I Study of Enzastaurin Combined with Pemetrexed in Advanced Non-small Cell Lung Cancer
23. A Multi-Institution Phase I/II Trial of Triweekly Regimen with S-1 Plus Cisplatin in Patients with Advanced Non-small Cell Lung Cancer
24. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy
25. Differences in the Quality of Information on the Internet about Lung Cancer between the United States and Japan
26. Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses
27. Comparative Chemotherapeutic Efficacy in Non-small Cell Lung Cancer Patients with Postoperative Recurrence and Stage IV Disease
28. Circulating Endothelial Cells in Non-small Cell Lung Cancer Patients Treated with Carboplatin and Paclitaxel
29. Influence of Previous Chemotherapy on the Efficacy of Subsequent Docetaxel Therapy in Advanced Non-small Cell Lung Cancer Patients
30. P2-290: Phase II study of S-1 in non-small cell lung cancer (NSCLC) patients previously treated with a platinum-based regimen
31. Common arm analysis: One approach to develop the basis for global standardization in clinical trials of non-small cell lung cancer
32. Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients
33. EGFR Mutation of Tumor and Serum in Gefitinib-Treated Patients with Chemotherapy-Naive Non–small Cell Lung Cancer
34. Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk
35. Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy
36. Immunohistochemical KIT (CD117) Expression in Thymic Epithelial Tumors
37. Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib
38. Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trials
39. P-460 Inter-observer variability in tumor response evaluation according to RECIST (Response Evaluation Criteria in Solid Tumors) guidelines
40. O-269 A phase II trial of pre-operative chemoradiotherapy followed by surgery in Pancoast tumors: initial report of Japan Clinical Oncology Group trial (JCOG 9806)
41. P-529 Combination phase I study of paclitaxel and nedaplatin (254-S) in patients with unresectable squamous cell carcinoma
42. Phase I trial of weekly docetaxel in elderly patients with non-small cell lung cancer
43. A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer
44. New drug and multimodality combinations in the treatment of advanced non[ndash ]small cell lung cancer
45. Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis
46. CYP2A6 Gene Deletion Reduces Susceptibility to Lung Cancer
47. A randomized controled trial of sulfamethoxazole/trimethoprim plus norfloxacin versus sulfamethoxazole/trimethoprim alone for the prophylaxis of bacterial infection during chemotherapy for lung cancer
48. Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.